Plasma atrial natriuretic peptide in essential hypertension. Comparison with normotensive subjects and effects of changes in dietary sodium intake
- PMID: 2969739
- DOI: 10.1093/ajh/1.2.112
Plasma atrial natriuretic peptide in essential hypertension. Comparison with normotensive subjects and effects of changes in dietary sodium intake
Abstract
Plasma levels of atrial natriuretic peptide (ANP) in 106 patients with essential hypertension with a supine mean blood pressure (mean +/- SEM) of 128.9 +/- 1.6 mmHg and not on treatment were significantly higher than those in 47 normotensive subjects (supine mean blood pressure 93.9 +/- 1.2 mmHg) with mean values of 17.2 +/- 1.1 and 8.6 +/- 0.6 pg/ml, respectively (P less than 0.001). Similar results were found in a subgroup of 35 hypertensive patients identically matched in terms of age, sex, and race with 35 normotensive subjects. Plasma levels of ANP were correlated significantly with age in normotensive subjects and with age and blood pressure in the hypertensive patients. In 12 hypertensive patients studied on a low (10 mmol sodium/day), on their usual sodium intake (around 120 mmol sodium/24 hr) and on a high (350 mmol sodium/day) intake, plasma ANP increased approximately twofold by the fifth day of the high sodium intake, but there was no significant difference between the plasma levels on their usual sodium intake and those on the fifth day of the low sodium intake. Supine mean blood pressure on the patients' usual sodium intake was 119.3 +/- 2.7 mmHg and was reduced to 110.0 +/- 3 mmHg by the fifth day of the low sodium intake (P less than 0.005). However, there was no significant difference between the blood pressure levels on their usual and high sodium intake (118.3 +/- 3.0 mmHg).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension.J Hypertens. 1994 Jul;12(7):809-13. J Hypertens. 1994. PMID: 7963510 Clinical Trial.
-
The effect of low and high sodium diets on plasma atrial natriuretic factor, the renin-aldosterone system and blood pressure in subjects with essential hypertension.Clin Endocrinol (Oxf). 1994 Jan;40(1):73-7. doi: 10.1111/j.1365-2265.1994.tb02446.x. Clin Endocrinol (Oxf). 1994. PMID: 8306484
-
Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients. Implications for the control of sodium balance.Circulation. 1994 Mar;89(3):1153-9. doi: 10.1161/01.cir.89.3.1153. Circulation. 1994. PMID: 8124802 Clinical Trial.
-
Effect of changes in sodium intake on cell transport parameters.Clin Exp Hypertens A. 1984;6(1-2):455-67. doi: 10.3109/10641968409062577. Clin Exp Hypertens A. 1984. PMID: 6365371 Review.
-
Methodology of sodium sensitivity assessment. The example of age and sex.Hypertension. 1991 Jan;17(1 Suppl):I109-14. doi: 10.1161/01.hyp.17.1_suppl.i109. Hypertension. 1991. PMID: 1986987 Review.
Cited by
-
Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.Drugs Aging. 1993 May-Jun;3(3):238-45. doi: 10.2165/00002512-199303030-00005. Drugs Aging. 1993. PMID: 8324299 Review.
-
[Effect of a beta 1-receptor blocker on the plasma level of atrial natriuretic peptide in patients with essential hypertension in the exercise test].Klin Wochenschr. 1990 May 4;68(9):476-84. doi: 10.1007/BF01648904. Klin Wochenschr. 1990. PMID: 2162449 German.
-
Harnessing the therapeutic potential of atrial natriuretic peptide.Klin Wochenschr. 1989 Sep 1;67(17):902-6. doi: 10.1007/BF01717347. Klin Wochenschr. 1989. PMID: 2530392 Review.
-
Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.J Clin Invest. 1993 Nov;92(5):2499-508. doi: 10.1172/JCI116858. J Clin Invest. 1993. PMID: 7901238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical